G.C. Monnot

Type de document

Co-auteur

P. Romero

N. Rufer

M. Hebeisen

A. Donda

D. Zehn

D.T. Utzschneider

D.E. Speiser

J. Schmidt

B. Salaun

N.P. Restifo

R. Perret

D.C. Palmer

S.A. Muljo

E. Merck

A. Martinez Usatorre

S. F. Lopes

E. Lanitis

Y. Ji

M. Irving

P.C. Ho

W. Held

L. Gattinoni

T.M. Escobar

M.N. Duong

J.C. Dudda

B. Couturaud

G. Coukos

W.C. Cheng

L. Carretero-Iglesia

C. Boudousquie

M. Allard

Date

Source

Serveur académique Lausannois (3)

Mot-clé

Expression (3) spectacle (2) Control (2) T cells (2) virus (1) thérapie (1) état (1) étable (1) persistance (1) besoin (1) plomb (1) infection (1) immunité (1) environnement (1) cytotoxicité (1) pièce d'exposition (1) biomarqueur (1) cancer (1) taux (1) Treatment (1) Cancer (1) Rates (1) Tumors--Growth (1) Virus diseases (1) Tumors (1) Therapeutics (1) Scarcity (1) Play (1) Persistence (1) Patients (1)

Documents écrit par G.C. Monnot (3) | parle de G.C. Monnot (0)

miR-155 Overexpression in OT-1 CD8+ T Cells Improves Anti-Tumor Activity against Low-Affinity Tumor Antigen.

G.C. Monnot et al. (27 mars 2020)

TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency.

M. Allard et al. (20 juil. 2017)

MicroRNA-155 Is Required for Effector CD8(+) T Cell Responses to Virus Infection and Cancer.

J.C. Dudda et al. (2013)